Regan J W, Nakata H, DeMarinis R M, Caron M G, Lefkowitz R J
J Biol Chem. 1986 Mar 15;261(8):3894-900.
Human platelet alpha 2-adrenergic receptors have been purified approximately 80,000-fold to apparent homogeneity by a five-step chromatographic procedure. The overall yield starting from the membranes is approximately 2%. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of radioiodinated protein from purified receptor preparations shows a single major band of Mr 64,000. The specific binding activity of the alpha 2-adrenergic receptor after four chromatographic steps is 14.5 nmol/mg protein. This value is consistent with the expected theoretical specific activity (15.6 nmol/mg) for a protein with a molecular mass of 64,000 daltons if it is assumed that there is one ligand-binding site/receptor molecule. The purified protein can be covalently labeled with the alkylating alpha-adrenergic ligand, [3H]phenoxybenzamine. This labeling is specific, and it shows that the Mr 64,000 protein contains the ligand binding site of the alpha 2-adrenergic receptor. In addition, the competitive binding of ligands to the purified receptor protein shows the proper alpha 2-adrenergic specificity. The alpha 2-adrenergic receptor contains an essential sulfhydryl residue. Thus, exposure of the purified receptor to the sulfhydryl-specific reagent, phenylmercuric chloride, resulted in an 80% loss of binding activity. This loss of binding activity was prevented when exposure to phenylmercuric chloride was done in the presence of alpha 2-adrenergic ligands, and it was reversed by subsequent exposure to dithiothreitol. Partial proteolysis of purified alpha 2-adrenergic receptors was obtained with Staphylococcus aureus V-8 protease, alpha-chymotrypsin, and papain. In a comparison with purified beta 2-adrenergic receptors, no common partial proteolytic products were found.
人血小板α₂ - 肾上腺素能受体已通过五步色谱法纯化至表观均一性,纯化倍数约为80,000倍。从膜开始的总产率约为2%。纯化受体制剂的放射性碘化蛋白的十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳显示一条主要条带,Mr为64,000。经过四个色谱步骤后,α₂ - 肾上腺素能受体的比结合活性为14.5 nmol/mg蛋白。如果假设每个受体分子有一个配体结合位点,那么对于分子量为64,000道尔顿的蛋白质,该值与预期的理论比活性(15.6 nmol/mg)一致。纯化的蛋白质可以用烷基化的α - 肾上腺素能配体[³H]苯氧苄胺进行共价标记。这种标记是特异性的,表明Mr 64,000的蛋白质含有α₂ - 肾上腺素能受体的配体结合位点。此外,配体与纯化的受体蛋白的竞争性结合显示出适当的α₂ - 肾上腺素能特异性。α₂ - 肾上腺素能受体含有一个必需的巯基残基。因此,将纯化的受体暴露于巯基特异性试剂氯化苯汞会导致结合活性损失80%。当在α₂ - 肾上腺素能配体存在下暴露于氯化苯汞时,这种结合活性的损失被阻止,并且随后暴露于二硫苏糖醇可使其逆转。用金黄色葡萄球菌V - 8蛋白酶、α - 胰凝乳蛋白酶和木瓜蛋白酶对纯化的α₂ - 肾上腺素能受体进行了部分蛋白水解。与纯化的β₂ - 肾上腺素能受体相比,未发现共同的部分蛋白水解产物。